These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29236652)

  • 1. Image Diagnosis: Nasal Furunculosis-A Dangerous Nose Infection.
    Bakshi SS
    Perm J; 2018; 22():17-076. PubMed ID: 29236652
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal Vestibular Furunculosis Presenting as the Rudolph Sign.
    Sakat MS; Kilic K; Ucuncu H
    J Craniofac Surg; 2015 Sep; 26(6):e545-6. PubMed ID: 26335324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005.
    Wiese-Posselt M; Heuck D; Draeger A; Mielke M; Witte W; Ammon A; Hamouda O
    Clin Infect Dis; 2007 Jun; 44(11):e88-95. PubMed ID: 17479931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
    Alou L; Cafini F; Sevillano D; Unzueta I; Prieto J
    Int J Antimicrob Agents; 2004 May; 23(5):513-6. PubMed ID: 15120734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A trial of the use of mupirocin in the nasal carriage of Staphylococcus aureus in medical personnel].
    Dmitrieva NV; Solodovnik FI; Petukhova IN
    Antibiot Khimioter; 2000; 45(3):35-8. PubMed ID: 10768065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
    Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a pharmacy-driven program to improve nasal mupirocin use.
    Neuner EA; Sekeres J; Ristich A; Skok J; Rosenblatt M; Fatica C; Fraser TG
    Am J Health Syst Pharm; 2011 Dec; 68(23):2222, 2224, 2226, 2228. PubMed ID: 22095809
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of MRSA-harboring patients: focused on mupirocin].
    Inoue M
    Jpn J Antibiot; 1996 May; 49(5):403-18. PubMed ID: 8752859
    [No Abstract]   [Full Text] [Related]  

  • 9. [The results and characteristics of the mupirocin (Bactroban) sanative treatment of intranasal Staphylococcus carriers in a large hospital].
    Lykova EA; Eremina LV; Sterkhova GV; Kozyreva SS
    Antibiot Khimioter; 2000; 45(6):25-8. PubMed ID: 10904806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients.
    Patel R
    Liver Transpl; 2001 Aug; 7(8):752-3. PubMed ID: 11780649
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage.
    Redhead RJ; Lamb YJ; Rowsell RB
    Br J Clin Pract; 1991; 45(4):252-4. PubMed ID: 1810357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent furunculosis: Efficacy of the CMC regimen--skin disinfection (chlorhexidine), local nasal antibiotic (mupirocin), and systemic antibiotic (clindamycin).
    Davido B; Dinh A; Salomon J; Roux AL; Gosset-Woimant M; Pierre I; Perronne C; Bernard L
    Scand J Infect Dis; 2013 Nov; 45(11):837-41. PubMed ID: 23848409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing postoperative Staphylococcus infections: an update.
    Grady M; Cullen JJ
    Surg Technol Int; 2003; 11():57-60. PubMed ID: 12931284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Managing children skin and soft tissue infections].
    Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mupirocin to prevent S. aureus infections.
    Farr BM
    N Engl J Med; 2002 Jun; 346(24):1905-6. PubMed ID: 12063377
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin.
    Kooistra-Smid AM; van Zanten E; Ott A; van Dijk SR; Beerthuizen GI; Vogels WH; van Belkum A; Verbrugh HA
    Burns; 2008 Sep; 34(6):835-9. PubMed ID: 18242873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease.
    Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL
    J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
    Lederer SR; Riedelsdorf G; Schiffl H
    Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal mupirocin to prevent postoperative infections.
    von Eiff C; Kipp F; Becker K
    N Engl J Med; 2002 Oct; 347(15):1207-8; author reply 1207-8. PubMed ID: 12374887
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mupirocin: its use].
    Janin N; Mignon A
    Ann Dermatol Venereol; 2000 May; 127(5):517-8. PubMed ID: 10863186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.